Results 181 to 190 of about 9,058 (209)
Some of the next articles are maybe not open access.
Perennial Allergic Rhinitis and Nasal Hyperreactivity
American Journal of Rhinology, 1998This article focuses on the nose as an accessible organ for research purposes, exploring whether the nose can be used to study lower airway processes.
openaire +4 more sources
Oral Vasoconstrictors in Perennial Non‐Allergic Rhinitis
Allergy, 1982Nasal airway resistance and nasal symptoms were evaluated in patients with perennial non‐allergic rhinitis before and after vasoconstrictory drugs and placebo taken orally. The patients were partly selected; these suffering mainly from nasal obstruction being tested.
P. Broms, Lars Malm
openaire +3 more sources
Allergic rhinitis: A perennial burden
Practice Nursing, 1996The seriousness of allergic rhinitis and its impact on patients' lives is grossly underestimated. Glenis Scadding discusses the new guidelines and how practice nurses can ease the burden.
openaire +2 more sources
Polymorphism of the CD14 gene in perennial allergic rhinitis
International Journal of Pediatric Otorhinolaryngology, 2006Allergic diseases have strong genetic backgrounds. Recently, a C-T polymorphism in the promoter region of CD14 has been associated with phenotypes of atopy in some populations. The aim of this study was to investigate the association of CD14/-159 polymorphism with total serum IgE levels and number of positive skin prick tests in Korean population with ...
Yun Mi Choi +5 more
openaire +3 more sources
The anticholinergic treatment of allergic perennial rhinitis
Journal of Allergy and Clinical Immunology, 1992Anticholinergic agents have been used for nonallergic rhinitis expressly to control rhinorrhea. In allergic rhinitis, rhinorrhea can be extremely troublesome and unresponsive to traditional pharmacotherapeutic rhinitis treatments. Anticholinergic agents, through their specific ability to decrease nasal secretory response, should have beneficial effects
openaire +3 more sources
Eosinophil Cationic Protein in Perennial Allergic Rhinitis
Auris Nasus Larynx, 1995For a quantitative investigation of eosinophil activation in perennial allergic rhinitis, eosinophil cationic protein (ECP) concentrations were measured by a radioimmunoassay in serum, nasal secretions (ECPWN) and in the supernatant of these nasal secretions (ECPsup) obtained from normal subjects and allergic patients.
Tsutomu Nakazawa +4 more
openaire +3 more sources
Non-Allergic Perennial Rhinitis
2018Non-infectious rhinitis can broadly be subdivided into two subclasses, allergic and non-allergic rhinitis, depending predominantly on whether or not an allergic aetiology is implicated. The term 'non-allergic rhinitis' is commonly applied to a diagnosis of any nasal condition in which the symptoms are identical to those seen in allergic rhinitis but an
Shahzada Ahmed, Jameel Muzaffar
openaire +2 more sources
Emerging drugs for the treatment of perennial allergic rhinitis
Expert Opinion on Emerging Drugs, 2016Allergic rhinitis is a worldwide health problem, currently affecting up to 40% of the general population, and characterized by the following symptoms in a variable degree of severity and duration: nasal congestion/obstruction, rhinorrhea, itchy nose and/or eyes, and/or sneezing.
LICARI, AMELIA +5 more
openaire +4 more sources
Pharmacotherapy of Perennial and Seasonal Allergic Rhinitis
Clinical Immunotherapeutics, 1995The options for pharmacotherapy of both perennial and seasonal allergic rhinitis continue to expand rapidly. The classic antihistamines will retain a place as effective drugs. They are without serious adverse effects, and are often available without a physician’s prescription.
openaire +2 more sources
Treatment of seasonal and perennial allergic rhinitis with prednisone and prednisolone
Journal of Allergy, 1956Abstract One hundred fifty-seven patients with ragweed pollinosis who had had no previous treatment or who had responded poorly to hyposensitization therapy were studied from Aug. 15 to Sept. 30, 1955. Seventy-nine were given prednisone or prednisolone at a daily dosage of 15 to 20 mg. for periods of one to thirty-one days.
Thomas Seideman, Earl B. Brown
openaire +3 more sources